Investors bet that Trump would be far less likely to crack down on controversial drug price hikes compared to his rival Hillary Clinton, who had spoken out against the increases and even had a plan to lower prices. Shares of a biotech ETF spiked 9% the day after Trump’selection.
But Trump put the entire drug industry on notice on Wednesday in an interview with Time.
“I’m going to bring down drug prices,” the president-elect told the magazine, which named him its Person of the Year. – READ MORE
